17 Results

People

  1. Kris
    Kris
  2. Seshan
    Seshan
  3. Rusch
    Rusch
  4. Miller
    Miller
  5. Riely
    Riely
  6. Bains
    Bains
  7. Rudin
    Rudin
  8. Yu
    Yu
  9. Chaft
    Chaft
  10. Downey
    Downey

Groups

  1. Biostatistics Service (17)
  2. Department of Medicine (17)
  3. Epidemiology and Biostatistics (17)
  4. Solid Tumor Oncology Division (17)
  5. Thoracic Oncology (17)
  6. Center for Pancreatic Cancer Research (9)
  7. Surgery (9)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  9. GSK Faculty (5)
  10. Human Oncology and Pathogenesis Program (4)
  1. "Biostatistics Service"
  2. "female"
  3. "Mark Kris"
Formats
  1. Journal Article (16)
  2. Conference Paper (1)
Groups
  1. Biostatistics Service (17)
  2. Department of Medicine (17)
  3. Epidemiology and Biostatistics (17)
  4. Solid Tumor Oncology Division (17)
  5. Thoracic Oncology (17)
  6. Center for Pancreatic Cancer Research (9)

More Groups

People
  1. Mark Kris (17)
  2. Venkatraman Seshan (9)
  3. Valerie Rusch (7)
  4. Vincent Miller (6)
  5. Gregory Riely (5)
  6. Charles Rudin (4)

More People

Years
  1. 2023 (2)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (2)
  6. 2004 (2)

More Years

Publications
  1. Cancer (4)
  2. Annals of Thoracic Surgery (3)
  3. Clinical Cancer Research (2)
  4. Journal of Clinical Oncology (2)
  5. JNCI: Journal of the National Cancer Institute (1)
  6. Journal for ImmunoTherapy of Cancer (1)

More Publications

Publishers
  1. Wiley Blackwell (4)
  2. Elsevier Science, Inc. (3)
  3. American Association for Cancer Research (2)
  4. American Society of Clinical Oncology (2)
  5. Elsevier Inc. (2)
  6. Biomed Central Ltd (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer
    Conference Paper

    Lengel, H. B.; Zheng, J.; Tan, K. S.; Liu, C. C.; Park, B. J.; Rocco, G.; Adusumilli, P. S.; Molena, D.; Yu, H. A.; Riely, G. J.; more...
    Mosby Elsevier (2023)

    Fulltext@MSK | Save
  • The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: A retrospective study
    Journal Article

    Zauderer, M. G.; Martin, A.; Egger, J.; Rizvi, H.; Offin, M.; Rimner, A.; Adusumilli, P. S.; Rusch, V. W.; Kris, M. G.; Sauter, J. L.; more...
    The Lancet Digital Health (2021)

    Fulltext@MSK | Save
  • Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
    Journal Article

    Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A. F.; Simone, C. B. 2nd; Gelblum, D. Y.; Wu, A. J.; Lee, N.; Kris, M. G.; more...
    Radiotherapy and Oncology (2020)

    Fulltext@MSK | Save
  • Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
    Journal Article

    Offin, M.; Feldman, D.; Ni, A.; Myers, M. L.; Lai, W. V.; Pentsova, E.; Boire, A.; Daras, M.; Jordan, E. J.; Solit, D. B.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Jordan, E.; Kim, H. R.; Dienstag, J.; Yu, H. A.; Sanchez-Vega, F.; Lito, P.; Berger, M.; Solit, D. B.; Hellmann, M.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
    Journal Article

    Arbour, K. C.; Kris, M. G.; Riely, G. J.; Ni, A.; Beal, K.; Daras, M.; Hayes, S. A.; Young, R. J.; Rodriguez, C. R.; Ahn, L.; more...
    Cancer (2018)

    Fulltext@MSK | Save
  • Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer
    Journal Article

    Miller, V. A.; Kris, M. G.; Shah, N.; Patel, J.; Azzoli, C.; Gomez, J.; Krug, L. M.; Pao, W.; Rizvi, N.; Pizzo, B.; more...
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • SCCRO expression correlates with invasive progression in Bronchioloalveolar carcinoma
    Journal Article

    Sarkaria, I. S.; Pham, D.; Ghossein, R. A.; Talbot, S. G.; Hezel, M.; Dudas, M. E.; Ebright, M. I.; Chuai, S.; Memoli, N.; Venkatraman, E. S.; more...
    Annals of Thoracic Surgery (2004)

    Fulltext@MSK | Save
  • Bcl-2 and bax expression in advanced non-small cell lung cancer: Lack of correlation with chemotherapy response or survival in patients treated with docetaxel plus vinorelbine
    Journal Article

    Krug, L. M.; Miller, V. A.; Filippa, D. A.; Venkatraman, E.; Ng, K. K.; Kris, M. G.
    Lung Cancer (2003)

    Fulltext@MSK | Save